Home › NDC Lookup › RxCUI directory › RxCUI 852920

Quinidine gluconate 324 MG Extended Release Oral Tablet — RxCUI 852920

RxNorm drug concept · Semantic clinical drug
RxCUI 852920 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI852920
Official nameQuinidine gluconate 324 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped9
Reported Medicaid activity (SDUD)185 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Quinidine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Quinidine has been used for decades and is proven to restore and help maintain normal heart rhythm in atrial fibrillation, atrial flutter, and certain serious ventricular arrhythmi...
  • Why did my doctor put me on quinidine instead of a newer heart medication?
  • Diarrhea is actually one of the most common side effects of quinidine — about 1 in 4 patients in one study experienced it. So yes, it's quite possibly related. The important thing...
  • I had a bout of diarrhea — is that from the quinidine, and should I stop taking it?
📖 Read our full Quinidine guide →

🕸️ Concept Web — How Quinidine gluconate 324 MG Extended Release Oral... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Quinidine gluconate 324 MG Extended Release Oral Tablet RxCUI 852920

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Quinidine 9068
    • Quinidine gluconate 35220
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Quinidine Extended Release Oral Tablet 373738
    • Quinidine gluconate Extended Release Oral Tablet 2646333
    • Quinidine Oral Product 1164185
    • Quinidine Pill 1164186
    • Quinidine gluconate Oral Product 2662102
    • Quinidine gluconate Pill 2660361
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Quinidine gluconate 324 MG 852919

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Quinidine gluconate 324 MG SCDC · 852919
  • Quinidine Extended Release Oral Tablet SCDF · 373738
  • Quinidine gluconate Extended Release Oral Tablet SCDFP · 2646333
  • Quinidine Oral Product SCDG · 1164185
  • Quinidine Pill SCDG · 1164186
  • Quinidine gluconate Oral Product SCDGP · 2662102
  • Quinidine gluconate Pill SCDGP · 2660361

📦 FDA Products & Package NDCs

3 products · 9 package NDCs
9 package NDCs map to RxCUI 852920 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51407-0288-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-288... Quinidine Gluconate Golden State Medical Supply 2019-10-24
53489-0141-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53489-141... Quinidine Gluconate Sun Pharmaceutical Industries, Inc. 1987-02-10
53489-0141-03 250 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53489-141... Quinidine Gluconate Sun Pharmaceutical Industries, Inc. 1987-02-10
53489-0141-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53489-141... Quinidine Gluconate Sun Pharmaceutical Industries, Inc. 1987-02-10
53489-0141-06 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53489-141-... Quinidine Gluconate Sun Pharmaceutical Industries, Inc. 1987-02-10
53489-0141-07 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53489-141-... Quinidine Gluconate Sun Pharmaceutical Industries, Inc. 1987-02-10
53489-0141-10 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53489-14... Quinidine Gluconate Sun Pharmaceutical Industries, Inc. 1987-02-10
53489-0141-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53489-141-... Quinidine Gluconate Sun Pharmaceutical Industries, Inc. 1987-02-10
71930-0016-12 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71930-016-12) Quinidine gluconate Eywa Pharma Inc 2022-03-20
Observed labelers: Sun Pharmaceutical Industries, Inc. (7) · Eywa Pharma Inc (1) · Golden State Medical Supply (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$5.0701
Range $5.0701–$5.0701 · middle 50% $5.0701–$5.0701 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.